Stay updated with breaking news from Nasdaq Regn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dodge & Cox grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,384,701 shares of the biopharmaceutical company’s stock after purchasing an additional 161,642 shares during […]
DE Burlo Group Inc. grew its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 20,590 shares of the biopharmaceutical company’s stock after buying an additional 8,900 shares during […]
Nwam LLC lessened its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.4% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 1,625 shares of the biopharmaceutical company’s stock after selling 112 shares during the quarter. Nwam LLC’s holdings in Regeneron Pharmaceuticals were worth $1,335,000 at the end of […]
Robert E. Landry to retire effective February 2024; Christopher Fenimore, long-standing Senior Vice President, Head of Accounting and Controller, to assume...
Candriam S.C.A. lowered its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 8.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 348,988 shares of the biopharmaceutical company’s stock after selling 33,980 shares during the quarter. Regeneron Pharmaceuticals accounts for about 1.8% […]